letrozole has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stanelle-Bertram, S | 1 |
| Beck, S | 1 |
| Mounogou, NK | 1 |
| Schaumburg, B | 1 |
| Stoll, F | 1 |
| Al Jawazneh, A | 1 |
| Schmal, Z | 1 |
| Bai, T | 1 |
| Zickler, M | 1 |
| Beythien, G | 1 |
| Becker, K | 1 |
| de la Roi, M | 1 |
| Heinrich, F | 1 |
| Schulz, C | 1 |
| Sauter, M | 1 |
| Krasemann, S | 1 |
| Lange, P | 1 |
| Heinemann, A | 1 |
| van Riel, D | 1 |
| Leijten, L | 1 |
| Bauer, L | 1 |
| van den Bosch, TPP | 1 |
| Lopuhaä, B | 1 |
| Busche, T | 1 |
| Wibberg, D | 1 |
| Schaudien, D | 1 |
| Goldmann, T | 1 |
| Lüttjohann, A | 1 |
| Ruschinski, J | 1 |
| Jania, H | 1 |
| Müller, Z | 1 |
| Pinho Dos Reis, V | 1 |
| Krupp-Buzimkic, V | 1 |
| Wolff, M | 1 |
| Fallerini, C | 1 |
| Baldassarri, M | 1 |
| Furini, S | 1 |
| Norwood, K | 1 |
| Käufer, C | 1 |
| Schützenmeister, N | 1 |
| von Köckritz-Blickwede, M | 1 |
| Schroeder, M | 1 |
| Jarczak, D | 1 |
| Nierhaus, A | 1 |
| Welte, T | 1 |
| Kluge, S | 1 |
| McHardy, AC | 1 |
| Sommer, F | 1 |
| Kalinowski, J | 1 |
| Krauss-Etschmann, S | 1 |
| Richter, F | 1 |
| von der Thüsen, J | 1 |
| Baumgärtner, W | 1 |
| Klingel, K | 1 |
| Ondruschka, B | 1 |
| Renieri, A | 1 |
| Gabriel, G | 1 |
1 other study available for letrozole and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
CYP19A1 mediates severe SARS-CoV-2 disease outcome in males.
Topics: Aromatase; COVID-19; Estradiol; Female; Humans; Letrozole; Male; SARS-CoV-2; Testosterone | 2023 |